Skip to main content

Advertisement

SpringerLink
Log in

Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriales infection: are they the same in neutropenic and non-neutropenic patients?

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Klastersky J, de Naurois J, Rolston K et al (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27:v111–v118. https://doi.org/10.1093/annonc/mdw325

    Article  PubMed  CAS  Google Scholar 

  2. Klastersky J, Ameye L, Maertens J et al (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30:S51–S59. https://doi.org/10.1016/j.ijantimicag.2007.06.012

    Article  PubMed  CAS  Google Scholar 

  3. Trecarichi EM, Tumbarello M, Spanu T et al (2009) Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58:299–307. https://doi.org/10.1016/j.jinf.2009.02.002

    Article  PubMed  Google Scholar 

  4. Rottier WC, Ammerlaan HSM, Bonten MJM (2012) Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother 67:1311–1320. https://doi.org/10.1093/jac/dks065

    Article  PubMed  CAS  Google Scholar 

  5. Hayden MK, Won SY (2018) Carbapenem-sparing therapy for extended-spectrum β-lactamase-producing E. coli and Klebsiella pneumoniae bloodstream infection: the search continues. JAMA J Am Med Assoc 320:979–981. https://doi.org/10.1001/jama.2018.12565

    Article  Google Scholar 

  6. Harris PNA, Tambyah PA, Lye DC et al (2018) Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance. JAMA J Am Med Assoc 320:984–994. https://doi.org/10.1001/jama.2018.12163

    Article  CAS  Google Scholar 

  7. Barlam TF, Cosgrove SE, Abbo LM et al (2016) Executive summary: Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis 62:1197–1202. https://doi.org/10.1093/cid/ciw217

    Article  PubMed  Google Scholar 

  8. Fawcett NJ (2018) Reducing carbapenem prescribing in high-use settings: it is possible, and it is good to talk. Intern Emerg Med 13:1179–1180. https://doi.org/10.1007/s11739-018-1959-y

    Article  PubMed  Google Scholar 

  9. Goodman KE, Lessler J, Cosgrove SE et al (2016) A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum β-lactamase-producing organism. Clin Infect Dis 63:896–903. https://doi.org/10.1093/cid/ciw425

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Ortega M, Marco F, Soriano A et al (2009) Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 63:568–574. https://doi.org/10.1093/jac/dkn514

    Article  PubMed  CAS  Google Scholar 

  11. Ben-Chetrit E, El Dahim MA, Bar-Meir M et al (2018) Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2018.12.003

    Article  PubMed  Google Scholar 

  12. Kim Y-J, Jung SM, Kang J et al (2019) Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia. Intern Emerg Med. https://doi.org/10.1007/s11739-018-02015-x

    Article  PubMed  Google Scholar 

  13. Castanheira M, Farrell SE, Krause KM et al (2014) Contemporary diversity of β-lactamases among enterobacteriaceae in the nine U.S. census regions and ceftazidime–avibactam activity tested against isolates producing the most prevalent β-lactamase groups. Antimicrob Agents Chemother 58:833–838. https://doi.org/10.1128/AAC.01896-13

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Morrissey I, Hackel M, Badal R et al (2013) A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals 6:1335–1346. https://doi.org/10.3390/ph6111335

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Pitout JD, Laupland KB (2009) Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159–166. https://doi.org/10.1075/jlp.15.5.03bha

    Article  Google Scholar 

  16. Mathers AJ, Peirano G, Pitout JDD (2015) The role of epidemic resistance plasmids and international high- risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev 28:565–591. https://doi.org/10.1128/CMR.00116-14

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Scheuerman O, Schechner V, Carmeli Y et al (2018) Comparison of predictors and mortality between bloodstream infections caused by ESBL-producing Escherichia coli and ESBL-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 39:660–667. https://doi.org/10.1017/ice.2018.63

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

    Filippo Lagi & Giampaolo Corti

  2. Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy

    Giampaolo Corti

Authors
  1. Filippo Lagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giampaolo Corti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Filippo Lagi.

Ethics declarations

Conflict of interest

The authors state that they have no conflicts of interest.

Statements on human and animal rights

The article does not contain any studies with human participants or animals performed by the author.

Informed consent

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lagi, F., Corti, G. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriales infection: are they the same in neutropenic and non-neutropenic patients?. Intern Emerg Med 14, 353–354 (2019). https://doi.org/10.1007/s11739-019-02047-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-019-02047-x

Search

Navigation